Academic interests
- Primary sclerosing cholangitis (PSC) and cholangiopathies.
- Liver inflammation, fibrosis, and vascular biology.
- Metabolic dysfunction-associated steatotic liver disease (MASLD, MASH) and alcohol-related liver disease (ALD), and hepatocellular carcinoma (HCC).
- Obesity, immunometabolism and inflammatory signaling in chronic liver disease.
Background
- PhD in Health Science, Biomolecular Medicine, Ghent University, conducted at VIB Center for Medical Biotechnology & Ghent University Hospital, Belgium (2020–2025)
- MSc in Biomedicine, UiT The Arctic University of Norway, Tromsø (2017–2019)
- BSc in Biology, The University of the Southern Caribbean, Trinidad and Tobago, Magna Cum Laude (2012–2016)
Awards
- Ghent University Special Research Fund (BOF) Laureate, Ghent, Belgium, 2024
- VIB “Scientist on Stage” Laureate, Veldhoven, The Netherlands, 2024
- Best Abstract and Presentation Prize, Dutch Endocrine Meeting, Eindhoven, The Netherlands, 2024
- Best Poster Award, International Liver Congress (EASL), Vienna, Austria, 2023
- Belgian Week of Gastroenterology (BWGE) Research Grant, Belgium, 2021
- Research Foundation Flanders (FWO) PhD Fellowship, Flanders, Belgium, 2020
Science communication
- Guest, VIB podcast Called to Science (Season 2), “Milton Antwi – Taking chances, making music out of science” (2025). Link
- Author, BioVox and VIB Blog, “Gender personalized medicine: the future of fatty liver disease treatment” (2024). Link
Tags:
Primary sclerosing cholangitis,
Cholangiocarcinoma,
Alcoholic liver disease,
MASLD,
Obesity,
Hepatocellular carcinoma,
Vascular biology
Publications
- Antwi MB, Lefere S, Clarisse D, et al. PPARα-ERRα crosstalk mitigates metabolic dysfunction-associated steatotic liver disease progression. Metabolism. 2025;164:156128. DOI link
- Antwi MB, Jennings A, Lefere S, et al. Unlocking therapeutic potential: exploring cross-talk among emerging nuclear receptors to combat metabolic dysfunction in steatotic liver disease. NPJ Metabolic Health and Disease. 2024. DOI link
- Antwi MB, Dumitriu G, Simón-Santamaria J, et al. Liver sinusoidal endothelial cells show reduced scavenger function and downregulation of FcγRIIb, yet maintain preserved fenestration in a mouse model of slowly progressing liver fibrosis. PLOS ONE. 2023;18(11). DOI link
- Heldens A, Antwi MB, Onghena L, et al. Mitochondrial dysfunction characterizes the deleterious multigenerational effects of maternal obesity on MASLD. JHEP Reports. 2025. DOI link
- Heldens A, Casteleyn C, Onghena L, Antwi MB, et al. The pan-PPAR agonist lanifibranor reduces portal pressure independent of fibrosis reduction through the splanchnic vasculature. Biomedicine & Pharmacotherapy. 2025. DOI link
- Onghena L, Heldens A, De Paepe K, Antwi MB, et al. The double-edged sword of metabolic and bariatric surgery: extending the biliary limb can trigger bacterial translocation, sepsis, and liver inflammation. International Journal of Surgery. 2025. DOI link
- Hutapea HML, Kridaningsih TN, Prasetyo KH, Antwi MB. Viral load as a risk factor of reverse transcriptase inhibitor drug resistance mutation in antiretroviral-treated people living with HIV/AIDS. Universa Medicina. 2021. DOI link
- Antwi FB, Osei SA, Peprah WK, Antwi MB, Antwi E. Integration of intercultural competence in innovative pedagogical methodology in nursing education. Abstract Proceedings International Scholars Conference. 2019. DOI link
Published
Feb. 18, 2026 12:23 PM
- Last modified
May 6, 2026 1:20 PM
